Pay for performance an ethical way to contain drug costs?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.570, 2009-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Do reference-based pricing policies really contain drug costs?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 320, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Is DM a recipe for containing costs?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 271, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Therapeutic Drug Monitoring: Do the Improved Outcomes Justify the Costs?

By Schumacher G.E. Barr J.T.

Clinical Pharmacokinetics, Vol. 40, Iss. 6, 2001-01 ,pp. : 405-409

Adis International

Access to resources Recommend Favorite

Is pharma to blame for soaring US healthcare costs?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 396, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

High cost of AD care: will therapy cut costs?

Inpharma, Vol. 1, Iss. 1291, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite